Who owns Etf Ser Solutions loncar cancer?
- Ticker: CNCR
- CUSIP Number: 26922a826
Tip: Access positions for across all investors
Analyze quarterly positions in Etf Ser Solutions loncar cancer with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Etf Ser Solutions loncar cancer stock
Who bought or sold Etf Ser Solutions loncar cancer this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Colony | 43k | $709k | 37% | Mar 2024 |
|
Citadel Advisors | 25k | $411k | 100% | Mar 2024 |
|
Morgan Stanley | 19k | $320k | 448% | Mar 2024 |
|
Jane Street | 12k | $191k | 100% | Mar 2024 |
|
Royal Bank of Canada | 10k | $173k | -9% | Mar 2024 |
|
Prospera Financial Services | 10k | $135k | 0% | Dec 2023 |
|
Blue Bell Private Wealth Management | 723.00 | $12k | -49% | Mar 2024 |
|
Coastal Investment Advisors | 539.00 | $9.0k | 100% | Mar 2024 |
|
Tower Research Capital | 496.00 | $8.2k | 100% | Mar 2024 |
|
UBS Group | 481.00 | $8.0k | -74% | Mar 2024 |
|
Advisor Group Holdings | 276.00 | $4.6k | 84% | Mar 2024 |
|
SOA Wealth Advisors | 150.00 | $2.5k | 0% | Mar 2024 |
|
Goss Wealth Management | 100.00 | $1.7k | 0% | Mar 2024 |
|
Clear Point Advisors | 27.00 | $448.000200 | 0% | Mar 2024 |
|
Who sold out of Etf Ser Solutions loncar cancer?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Susquehanna International | Sep 2023 | 36k | $399k |
LPL Financial | Sep 2023 | 12k | $128k |